These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32212732)

  • 1. Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73.
    Beatty JW; Lindsey EA; Thomas-Tran R; Debien L; Mandal D; Jeffrey JL; Tran AT; Fournier J; Jacob SD; Yan X; Drew SL; Ginn E; Chen A; Pham AT; Zhao S; Jin L; Young SW; Walker NP; Leleti MR; Moschütz S; Sträter N; Powers JP; Lawson KV
    J Med Chem; 2020 Apr; 63(8):3935-3955. PubMed ID: 32212732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of WO2017098421: GSK's benzothiazine compounds as CD73 inhibitor filings.
    Gong YP; Wan RZ; Liu ZP
    Expert Opin Ther Pat; 2018 Feb; 28(2):167-171. PubMed ID: 29166791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Novel Non-Nucleoside Inhibitors Interacting with Dizinc Ions of CD73.
    Shi C; Chang L; Wang J; Dai J; Xu W; Tang J; Mei W; Zhang C; Wang Z; Liao Y; Zhang X; Jiang W; Zhang G; Zhao Z; Xu Y; Zhu L; Li H
    J Med Chem; 2024 Jun; 67(11):9686-9708. PubMed ID: 38809692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors.
    Sharif EU; Kalisiak J; Lawson KV; Miles DH; Newcomb E; Lindsey EA; Rosen BR; Debien LPP; Chen A; Zhao X; Young SW; Walker NP; Sträter N; Scaletti ER; Jin L; Xu G; Leleti MR; Powers JP
    J Med Chem; 2021 Jan; 64(1):845-860. PubMed ID: 33399453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes.
    Bhattarai S; Pippel J; Scaletti E; Idris R; Freundlieb M; Rolshoven G; Renn C; Lee SY; Abdelrahman A; Zimmermann H; El-Tayeb A; Müller CE; Sträter N
    J Med Chem; 2020 Mar; 63(6):2941-2957. PubMed ID: 32045236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Substituted-1,2,3-triazolo nucleotide analogues as CD73 inhibitors, their synthesis, in vitro screening, kinetic and in silico studies.
    Ghoteimi R; Braka A; Rodriguez C; Cros-Perrial E; Tai Nguyen V; Uttaro JP; Mathé C; Chaloin L; Ménétrier-Caux C; Jordheim LP; Peyrottes S
    Bioorg Chem; 2021 Feb; 107():104577. PubMed ID: 33450542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of natural product ellagic acid as a potent CD73 and CD39 dual inhibitor.
    Wang Y; Wang C; Zhu Y; Zhang Y; Chen B; Wu Y; Yao J; Miao Z
    Bioorg Med Chem Lett; 2021 Feb; 34():127758. PubMed ID: 33359608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of AB680: A Potent and Selective Inhibitor of CD73.
    Lawson KV; Kalisiak J; Lindsey EA; Newcomb ET; Leleti MR; Debien L; Rosen BR; Miles DH; Sharif EU; Jeffrey JL; Tan JBL; Chen A; Zhao S; Xu G; Fu L; Jin L; Park TW; Berry W; Moschütz S; Scaletti E; Sträter N; Walker NP; Young SW; Walters MJ; Schindler U; Powers JP
    J Med Chem; 2020 Oct; 63(20):11448-11468. PubMed ID: 32614585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action.
    Geoghegan JC; Diedrich G; Lu X; Rosenthal K; Sachsenmeier KF; Wu H; Dall'Acqua WF; Damschroder MM
    MAbs; 2016; 8(3):454-67. PubMed ID: 26854859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody-Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function.
    Jin R; Liu L; Xing Y; Meng T; Ma L; Pei J; Cong Y; Zhang X; Ren Z; Wang X; Shen J; Yu K
    Mol Cancer Ther; 2020 Nov; 19(11):2340-2352. PubMed ID: 32943546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface.
    Rahimova R; Fontanel S; Lionne C; Jordheim LP; Peyrottes S; Chaloin L
    PLoS Comput Biol; 2018 Jan; 14(1):e1005943. PubMed ID: 29377887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Small and Bifunctional Molecules Targeting PD-L1/CD73 for Cancer Dual Immunotherapy.
    Wang S; Kong Z; Shi Y; Shao C; Wang W; Su Z; Liu J; Zhou Y; Fei X; Cheng B; Chen J; Lu Y; Xiao J
    J Med Chem; 2024 Jun; 67(11):9447-9464. PubMed ID: 38748913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39.
    Jeffrey JL; Lawson KV; Powers JP
    J Med Chem; 2020 Nov; 63(22):13444-13465. PubMed ID: 32786396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017-present).
    Nocentini A; Capasso C; Supuran CT
    Expert Opin Ther Pat; 2021 Oct; 31(10):867-876. PubMed ID: 33909515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model.
    Tsukui H; Horie H; Koinuma K; Ohzawa H; Sakuma Y; Hosoya Y; Yamaguchi H; Yoshimura K; Lefor AK; Sata N; Kitayama J
    BMC Cancer; 2020 May; 20(1):411. PubMed ID: 32397971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of Non-Nucleotide CD73 Inhibitors Using a Molecular Docking and 3D-QSAR Approach.
    Bhujbal SP; Hah JM
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD73 inhibition by purine cytotoxic nucleoside analogue-based diphosphonates.
    Dumontet C; Peyrottes S; Rabeson C; Cros-Perrial E; Géant PY; Chaloin L; Jordheim LP
    Eur J Med Chem; 2018 Sep; 157():1051-1055. PubMed ID: 30176535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host surface ectonucleotidase-CD73 and the opportunistic pathogen,
    Lee JS; Chowdhury N; Roberts JS; Yilmaz Ö
    Virulence; 2020 Dec; 11(1):414-429. PubMed ID: 32419582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of CD73 enzymatic activity using luminescence-based and colorimetric assays.
    Allard B; Cousineau I; Spring K; Stagg J
    Methods Enzymol; 2019; 629():269-289. PubMed ID: 31727245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.
    Gao ZW; Wang HP; Lin F; Wang X; Long M; Zhang HZ; Dong K
    BMC Cancer; 2017 Feb; 17(1):135. PubMed ID: 28202050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.